Analysis of BHEEMA CEMENTS LTD. (BHEEMACEM)
Bheema Cements Ltd. has shown a recent downward trend in its stock price, with the price closing at 23.07 on the most recent trading day. The Relative Strength Index (RSI) indicator is at 36.76, indicating that the stock is approaching oversold conditions but has not yet reached them.
The Moving Average Convergence Divergence (MACD) indicator is negative at -0.12136, with the MACD line below the signal line, suggesting a bearish signal. However, the MACD histogram is also negative at -0.14575, indicating a potential reversal in the downward trend.
The stock's Simple Moving Average (SMA) is at 24.944, which is slightly above the closing price, indicating a short-term bearish trend. The Exponential Moving Average (EMA) and Weighted Moving Average (WMA) are also above the closing price, further supporting the bearish outlook.
Overall, based on the technical indicators, Bheema Cements Ltd. is currently in a bearish phase, but traders should closely monitor the RSI and MACD for potential reversal signals in the future.
Main Statystic ðŸ§
The company's financials show a strong cash flow, with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet indicates a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The book value per share is $4.837, total cash per share is $4.379, and the total debt to equity ratio is 140.968.
In terms of profitability, the company has a profit margin of 26.31% and an operating margin of 30.74%. The return on assets is 22.07% and the return on equity is 147.25%. The fiscal year ends on September 30, 2023, with the most recent quarter ending on March 31, 2024.
The income statement shows an EBITDA of $131.39 billion, revenue of $381.62 billion, diluted EPS of 6.44, gross profit of $169.15 billion, revenue per share of $24.54, and net income to common of $100.39 billion. The quarterly revenue and earnings growth are negative at -4.3% and -2.2% respectively.
In terms of stock statistics, the short ratio is 1.66, with 94.31 million shares shorted out of 1.53 billion float shares. The company has a market capitalization of $2.91 trillion.
Valuation metrics include a PEG ratio of 26.21, forward PE of 26.21, trailing PE of 29.43, price to book ratio of 39.18, price to sales ratio of 7.62, enterprise value of $2.95 trillion, enterprise to EBITDA of 22.75, and enterprise to revenue of 7.73.
The stock price summary shows a beta of 1.26, 50-day moving average of $173.69, 200-day moving average of $180.79, 52-week low of $164.08, 52-week high of $199.62, and a 52-week change of 8.25%.
Regarding dividends and splits, the company has a payout ratio of 14.93%, with a forward annual dividend rate of $1 and a trailing annual dividend rate of $0.97. The 5-year average dividend yield is 0.73%, with a forward annual dividend yield of 0.53% and a trailing annual dividend yield of 0.51%. The dividend date is May 16, 2024, and the ex-dividend date is May 10, 2024. The last split date was on August 31, 2020, with a 4-for-1 split.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.
Income statement 💸
These are the revenue figures. Here are the conclusions:
1. The company's sales revenue has been increasing steadily over the past four fiscal years.
2. The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) has also shown a positive trend, indicating operational efficiency.
3. Net income has been growing consistently, reflecting the company's profitability.
4. Despite fluctuations in other income and expenses, the company has managed to maintain a strong financial performance.
5. The basic and diluted earnings per share (EPS) have shown a slight variation but have generally been stable.
6. The company has effectively managed its operating expenses in relation to its revenue growth.
7. The non-operating interest expenses have been relatively stable over the years.
8. The company has been able to generate continuous positive net income from its core operations.
9. Overall, the financial performance of the company, as indicated by its revenue figures, seems to be on a positive trajectory.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated but generally show an increasing trend.
3. Non-current assets have also been increasing steadily.
4. Total liabilities have been increasing, but at a slower pace compared to total assets.
5. Shareholders' equity has shown an increasing trend, indicating a healthy financial position.
6. The company has been investing in machinery, furniture, and equipment, as seen in the non-current assets section.
7. There is a significant amount of cash and cash equivalents in the current assets, indicating liquidity.
8. Long-term debt is a significant portion of the liabilities, but the company has been managing it well.
9. Retained earnings have been positive, contributing to the growth in shareholders' equity.
10. Overall, the company seems to be in a stable financial position with consistent growth in assets and equity.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's financial activities seem to be well-managed, with a focus on maintaining a healthy cash position while investing in growth and returning value to shareholders.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and years, with the numbers generally increasing compared to the previous year's earnings. This indicates potential growth and improvement in the company's financial performance according to analysts' projections.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest that the company has been experiencing significant growth in the past but analysts expect the growth rate to moderate in the coming years, although it is still expected to be positive.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.MACD of BHEEMACEM